StockData
Stevanato Group S.p.A. logo

Stevanato Group S.p.A. (STVN) stock

STVNNYSESurgical & Medical Instruments & Apparatus
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 4, 2026Score 8/30
$15.25−0.28 (-1.80%)

Close on Nov 17, 2026Market cap $4.62BP/E 27.1Yield –

Stevanato Group S.p.A. r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2025 it was €25.44M, down 19.7% from the year before. The highest annual figure on record is €35.67M in fiscal 2023.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025€25.44M-19.7%
FY2024Dec 31, 2024€31.67M-11.2%
FY2023Dec 31, 2023€35.67M+3.7%
FY2022Dec 31, 2022€34.39M+16.1%
FY2021Dec 31, 2021€29.62M+70.3%
FY2020Dec 31, 2020€17.39M+122.2%
FY2019Dec 31, 2019€7.83M–

More Stevanato Group S.p.A. figures

See a number that looks wrong?